FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new chroman derivatives of formula I: , or to their pharmaceutically acceptable salts where m has a value of 0; p has a value of 2; q has a value of 2; Ar represents phenyl optionally substituted with halogen atom; R2 represents ; X represents -NR9-; n has a value of 2 or 3; each R3, R4, R5 and R6 independently represents hydrogen or C1-12alkyl; each R7 and R8 independently represents either hydrogen, or C1-12-alkyl, or R7 and R8 together with nitrogen whereto attached, can form 4-6-members ring, or one of R7 and R8 and one of R5 and R6 together with atoms whereto attached can form 4-6-members ring; and R9 represents hydrogen or C1-12-alkyl, or when R7 represents hydrogen or methyl, R9 together with R8 and atoms whereto attached can form 6-members ring.
EFFECT: preparation of chroman new derivatives and the pharmaceutical composition containing compounds of formula (I).
22 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
TETRALIN AND INDANE DERIVATIVES AND USE THEREOF AS 5-HT ANTAGONISTS | 2005 |
|
RU2388748C2 |
TETRALINE AND INDANE DERIVATIVES AND USE THEREOF | 2005 |
|
RU2389723C2 |
4-PYPERAZINYL-BENZEN-SULFANYLINDOLES WITH AFFINITY TO 5-HT6 RECEPTOR | 2003 |
|
RU2324693C2 |
INDOLE DERIVATIVES SHOWING AFFINITY TO 5-HT RECEPTORS | 2002 |
|
RU2294932C2 |
BENZIMIDAZOLE AND INDOLE DERIVATIVES AS SELECTIVE 5-HT6 AND/OR 5-HT2A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415138C2 |
2,5-SUBSTITUTED TETRAHYDROISOQUINOLINE AND A PHARMACEUTICAL MODULATION COMPOSITION 5-НТ6 | 2004 |
|
RU2327689C2 |
BENZOXAZINE DERIVATIVES AND THEIR APPLICATION | 2004 |
|
RU2354651C2 |
CHROMANE DERIVATIVES AND USE THEREOF AS 5-HT RECEPTOR LIGANDS | 2005 |
|
RU2396264C2 |
SUBSTITUTED 2-ALKYLSULFANYL-3-SULFONYL-PYRAZOLO[1,5-a]PYRIMIDINES, SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2008 |
|
RU2393159C1 |
SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULPHONYL-PYRAZOLO[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD OF OBTAINING THEM | 2008 |
|
RU2369600C1 |
Authors
Dates
2010-08-10—Published
2005-12-13—Filed